Walk down the supplement aisle and creatine HCl looks like the upgrade. Smaller scoop, fully dissolves, no loading, no bloat, a claim of 38 times or even 59 times better solubility printed right on the tub. Creatine monohydrate, by contrast, is the same cheap white powder people were buying in 1995. The obvious question is whether the newer form has earned its premium, and the short answer is no, not yet. Creatine monohydrate has hundreds of human trials, decades of safety data, and direct measurements of creatine going into muscle and brain. Creatine HCl has a handful of small performance studies, none of which measured tissue creatine at all, and every head to head comparison so far has found it performs about the same as monohydrate, not better.
That’s the summary. The details matter, though, because the marketing around creatine HCl is built on a chain of reasoning that sounds plausible and falls apart when you look at where each link came from. I want to walk through that chain, study by study, so you can judge it yourself.
What the Evidence Actually Shows
Here is the state of play as of late 2026, with the caveat that this is a moving field.
Creatine monohydrate raises muscle creatine by roughly 20 to 40 percent and brain creatine by roughly 5 to 15 percent in the studies that have measured it directly, with the muscle figure resting on biopsy work going back to the early 1990s and the brain figure on magnetic resonance spectroscopy. Those numbers come from the 2022 critical review of creatine forms by Kreider, Jäger and Purpura, which is the single most useful document on this topic and the one I’d tell anyone to read first.
Creatine HCl is a real, bioavailable source of creatine. Nobody serious disputes that. The salt dissociates in the stomach and delivers creatine to the blood. What has never been shown is that it delivers more creatine to muscle or brain than monohydrate at the same dose, or that the tiny doses on the label, typically 750 mg to 2 g, do what 3 to 5 g of monohydrate does. Four randomized comparisons in humans, published between 2015 and 2025, all found the two forms roughly equivalent. That is a null result for superiority, and it has been replicated.
Where the 38 Times Number Came From
Almost every creatine HCl page on the internet cites a figure of 38 times greater solubility, and a lot of them quietly upgrade that to 38 times greater absorption or bioavailability. The number is real, but it means something narrower than the marketing implies.
It comes from a 2010 laboratory paper by Gufford and colleagues at the University of Nebraska Medical Center, published in the Journal of Dietary Supplements. The team synthesized several creatine salts and measured how much of each would dissolve in water at 25 degrees Celsius. They found that creatine hydrochloride was about 38 times more soluble than creatine monohydrate, and creatine mesylate about 30 times. That is a bench chemistry result. No humans, no blood, no muscle.
There is also a detail in that paper that rarely makes it onto product pages. The Kreider review points out that the monohydrate solubility was measured in a solution that had settled at a pH of 8.6, while the hydrochloride was measured at a pH of 0.3, which is roughly the acidity of concentrated stomach acid. Creatine dissolves far better in acid, so a good chunk of the 38 fold difference is the acid doing the work, not some special property of the salt. Dissolve monohydrate in orange juice and the gap shrinks considerably.
The same Gufford paper did one more thing that is worth knowing. The researchers tested how well the different salts crossed a layer of human intestinal cells grown in the lab, a standard model for gut absorption. Creatine citrate crossed less well than monohydrate. Creatine hydrochloride crossed about the same. So the one absorption relevant measurement in the paper that launched the solubility claim found no advantage for HCl.
Why Solubility Is the Wrong Thing to Care About
The argument for creatine HCl runs like this. Monohydrate doesn’t fully dissolve, therefore some of it isn’t absorbed, therefore a more soluble form is absorbed better, therefore you need less of it. Every step after the first is wrong.
Monohydrate that settles at the bottom of your glass is not lost. If you swirl and drink it, it dissolves in your stomach, where the pH is low enough to dissolve creatine easily and, usefully, low enough to stop creatine from breaking down into creatinine. The Kreider review summarizes decades of tracer and urine collection work showing that orally ingested creatine monohydrate is close to 100 percent bioavailable, meaning nearly all of it either gets taken up by tissue or shows up in urine as creatine. There is no absorption problem for a more soluble form to solve.
The more interesting bottleneck is the creatine transporter, a protein called SLC6A8 that pulls creatine from the blood into muscle and brain cells. That transporter doesn’t know or care what salt the creatine arrived as. Once creatine is in the blood it’s just creatine, whether it came from a steak, a monohydrate powder or a hydrochloride capsule. Anyone claiming a form of creatine gets more into tissue needs to show it with a biopsy or a spectroscopy scan, and for HCl nobody has.
One more molecular weight point, because it matters for dosing. Creatine monohydrate is about 88 percent creatine by weight. Creatine HCl is about 78 percent. So 5 g of HCl actually contains a little less creatine than 5 g of monohydrate, not more. The idea that a 750 mg scoop of HCl could match a 5 g scoop of monohydrate would require HCl to be around eight times more effective per gram of actual creatine, which is an extraordinary claim.
The Head to Head Trials, One at a Time
Here is every randomized human comparison of creatine HCl against creatine monohydrate that I can find in the peer reviewed literature. There are four. Read them for what they measured, not just for the headline.
The 2015 de França study from Brazil put 40 recreational weightlifters into four groups for four weeks of resistance training: 5 g per day of monohydrate, 5 g per day of HCl, 1.5 g per day of HCl, or a placebo of resistant starch. Leg press strength rose significantly in all three creatine groups, and there was no statistically significant difference between any of the groups on strength. The authors leaned on some within group changes in fat mass and fat free mass to conclude that only HCl changed body composition, but with 10 people per group and no between group difference, that’s a weak basis for a headline. The Kreider review also noted the dose arithmetic: the 1.5 g HCl group got about 35 g of actual creatine over the month while the monohydrate group got about 132 g, so the fact they ended up similar on strength tells you more about how little creatine four weeks of training needs to show an effect than about HCl being special.
The 2020 Tayebi and Arazi study, published in Science and Sports, gave 36 trained young men one of four protocols for seven days: 20 g per day of monohydrate, 3 g per day of monohydrate, 3 g per day of HCl, or placebo. The claim being tested was that HCl absorbs so well it needs no loading phase. The result was that 3 g of HCl did not outperform either monohydrate dose on anaerobic performance or on testosterone and cortisol. Seven days is short, and the sample is small, but the direction of the result is not ambiguous.
The 2025 Eghbali, Riahy and Arazi study in Sport Sciences for Health followed 36 male Iranian soldiers aged 18 to 28 through eight weeks of resistance training with HCl, monohydrate or placebo, 12 per group. Both creatine groups improved performance and body composition relative to placebo and showed some changes in oxidative stress markers, but the authors’ own conclusion was that HCl did not produce more effects than monohydrate, and neither form changed muscle damage markers. This is another equivalence result.
The most rigorous comparison to date is the 2025 trial from Colombia published in the Journal of the International Society of Sports Nutrition, with Richard Kreider among the authors. It was a three arm, placebo controlled, triple blind randomized trial in elite handball and softball players aged 18 to 28. Participants took 5 g per day of micronized monohydrate, 5 g per day of creatine HCl, or 5 g of maltodextrin for eight weeks alongside their normal training, and 31 completed the analysis. Body composition was measured by DXA and strength by isokinetic dynamometry and jump testing on force plates. The result: no statistically significant differences between groups on any measure. Both creatine groups improved jump performance within group with similar small effect sizes, both gained fat free mass, and only the monohydrate group showed an increase in fat free mass index. The authors’ plain conclusion was that HCl does not outperform monohydrate even at low doses in elite athletes.
One pattern across all four trials is worth naming. Every one of them was run alongside a training program, which means the placebo groups also improved and the creatine effect had to be found on top of that. That design is fine for asking whether a supplement helps athletes. It is a blunt instrument for asking whether one form of creatine loads tissue better than another, because strength and jump height are several steps removed from muscle creatine content. Add those up and you have roughly 140 people across four trials, all showing the same thing. Creatine HCl works about as well as monohydrate at similar doses. It does not work better. And none of the four trials measured the thing that would settle the question, which is how much creatine ended up in muscle.
The Study Nobody Has Done
That last point deserves its own section because it is the entire problem.
The standard for proving a new form of creatine works is not a strength test. Strength improves with training whether you take creatine or not, which is why placebo groups in these trials also get stronger. The standard is a direct measurement of tissue creatine, either from a muscle biopsy or from magnetic resonance spectroscopy, before and after supplementation, compared against monohydrate at an equal creatine dose. That is how monohydrate itself was validated, and it is how other novel forms have been tested and found wanting. When Jagim and colleagues ran exactly that experiment on buffered creatine in 2012, they found it raised muscle creatine no more than monohydrate at matched doses, and less at the low dose on the label. When Spillane and colleagues ran it on creatine ethyl ester in 2009, the ester raised muscle creatine less than monohydrate and pushed serum creatinine up more than two fold, which is not a result you want.
For creatine HCl that experiment has not been published. The 2022 Kreider review states that there are no data showing HCl is absorbed more effectively than monohydrate in humans, promotes greater muscle creatine retention at the same dose, or works at lower doses. A 2022 survey of creatine products on Amazon by Escalante, Schoenfeld and colleagues, which used the Kreider classification, put HCl in the some evidence category with that same caveat: bioavailable, but no evidence of superiority or of low dose efficacy.
What about the 70 percent better plasma uptake figure that the leading HCl brand cites? Their own product page describes it as a crossover study presented at a 2009 conference, with the research held on file rather than published. A conference presentation from 17 years ago that never made it through peer review is not something I can evaluate, and neither can you. Even taken at face value, higher plasma creatine after a dose does not prove more creatine reached muscle. The Kreider review makes this point explicitly: a higher blood level can mean faster absorption, or it can mean slower uptake into tissue, and only a tissue measurement can tell you which.
What Micro Dosing Asks You to Believe
The commercial pitch for creatine HCl is that you can take a fraction of the dose. The most prominent branded creatine HCl powder recommends 750 mg per 100 pounds of body weight and states that each 750 mg serving delivers the same benefits as 5,000 mg of monohydrate.
Let’s take that claim seriously and ask what it would require. A 750 mg scoop of creatine HCl contains about 585 mg of creatine. Classic experiments by Harris in 1992, summarized in the Kreider review, found that swallowing 1 g or less of creatine barely moves blood creatine, rarely above 100 micromoles per liter, while 5 g of monohydrate pushes it to around 800. Blood creatine needs to get well above baseline for the transporter to load muscle efficiently. So a 585 mg dose is, on the best available pharmacology, below the threshold where creatine loading happens at all, regardless of salt form. For the label dose to work as claimed, creatine HCl would need to bypass everything we know about how creatine gets into cells.
It is worth stating plainly that no published study has tested whether 750 mg per day of creatine HCl raises muscle or brain creatine. The lowest dose that has been compared against monohydrate in a trial is 1.5 g per day for four weeks in the de França study, and that trial measured strength, not tissue creatine. The 3 g per day doses in the Tayebi and Eghbali studies are already four times the label recommendation.
There is one new piece of evidence about low dose HCl, and I include it because it’s the kind of study the site’s rules say we should report even when it’s thin. In 2026 a group including Sergej Ostojic posted a preprint on medRxiv describing a 28 day single arm safety pilot of low dose creatine HCl in 11 healthy adults, funded by the company that sells the leading HCl product. It is a safety study, it has no comparison group, it has not been peer reviewed, and it did not measure creatine in muscle or brain. It tells you that a month of small doses didn’t produce alarming blood work in 11 people. It does not tell you the small doses did anything.
Safety, Regulators and the Price Tag
On safety, the honest position is that creatine HCl is probably fine and monohydrate is definitely fine. Monohydrate has the safety record: the Kreider review catalogs studies up to 21 months in athletes at 5 to 10 g per day with no medically significant adverse effects, and the International Society of Sports Nutrition position stand reached the same conclusion. HCl at 3 to 5 g per day for eight weeks in the trials above produced no safety signals, and since it dissociates into creatine and a small amount of hydrochloric acid, there’s no obvious mechanism for harm. But the long term data simply don’t exist for HCl the way they do for monohydrate. If you have kidney concerns or take medication, talk to a doctor before starting either.
On regulation, the United States and Europe treat these forms differently, and it’s worth being precise. In the US, creatine of any form is sold as a dietary supplement under DSHEA, which means the FDA does not review efficacy before sale and the FTC is the body that would act against unsubstantiated advertising claims. Neither agency has adopted the tissue measurement standard the Kreider review proposes, which is why solubility claims can sit on labels unchallenged. In the European Union, creatine monohydrate is a long established food ingredient and carries an authorized health claim from EFSA, the European Food Safety Authority, stating that 3 g per day increases physical performance in successive bursts of short term, high intensity exercise. That claim was substantiated on monohydrate trials and applies in the EU, not the US. I could not find any EU authorized claim specific to creatine HCl. A Spanish regulator’s 2025 opinion also confirmed that micronized monohydrate is not a novel food in the EU because monohydrate was consumed there before 1997, a status that a chemically distinct salt would not automatically inherit.
On price, the gap is large. The Escalante survey of 175 creatine products on Amazon in early 2022 found that products containing only monohydrate averaged 12 cents per gram, while products containing only alternative forms averaged 26 cents, and the three standalone HCl products they priced came in at 55 cents per gram. Current list prices tell the same story. A 1 kilogram bag of micronized monohydrate from a major US bulk seller lists at $29.97, about 3 cents per gram. The leading HCl powder lists at $24.99 for 64 servings of 750 mg, which is 48 g of powder, or about 52 cents per gram. If you follow the label and take one 750 mg scoop, HCl costs around 39 cents a day. If you take enough HCl to match the 3 to 5 g of creatine that the research actually supports, you’re paying $2 to $3 a day for what monohydrate delivers for about a dime.
If Your Reason for Taking Creatine Is Your Brain
This site is about creatine and cognition, so I want to be direct about what the brain literature says regarding form. It says nothing about creatine HCl, because no cognition study has used it.
A 2024 meta analysis in Frontiers in Nutrition by Xu and colleagues pooled 16 randomized trials with 492 participants aged 21 to 76, including healthy adults and some clinical groups, and reported a small positive effect of creatine supplementation on memory, with a standardized mean difference of about 0.31, plus effects on attention time and processing speed rated as low certainty. The authors state that creatine monohydrate was the form used in every included study. That paper also carries a 2025 corrigendum correcting a mistranslated passage in its attention results, which is a reminder to read the corrected version. Separately, in November 2024, EFSA’s expert panel reviewed 21 human trials and declined to authorize a health claim linking creatine to improved cognitive function, finding that effects seen with short high dose protocols of 20 g per day did not hold up at the 3 g per day doses that would be used continuously, and that the evidence for a mechanism in healthy adults was weak. That EFSA opinion binds claims made in the EU, not in the US, but it’s a sober read on where the evidence stands.
The point for form selection is simple. The brain studies that exist, positive and null alike, were done with monohydrate, usually at 5 to 20 g per day. Brain creatine rises modestly and slowly with monohydrate, in the 5 to 15 percent range across several weeks in the spectroscopy studies. There is no evidence that HCl raises brain creatine at all, because nobody has looked, and there is certainly no evidence that a 750 mg dose of anything does. If you are taking creatine because you read about the memory research, you should be taking the form the memory research used, at a dose in the range it used.
What Would Change the Picture
I’m not attached to monohydrate. I’m attached to evidence, and a single well designed study could move creatine HCl from unproven to proven. It would need to give equal creatine doses of HCl and monohydrate, measure muscle creatine by biopsy or brain creatine by spectroscopy before and after four to eight weeks, and ideally include the low label dose as a third arm. If HCl matched monohydrate at equal doses, that would be a fair result and would justify choosing it for people who like how it mixes. If 750 mg of HCl matched 5 g of monohydrate on tissue creatine, that would be remarkable and I would say so loudly. The company selling the leading HCl product has been in business for well over a decade and could have funded that study many times over. The fact that it has instead published a small safety pilot in 2026 tells you something.
Until then, the honest answer to creatine HCl vs monohydrate is that monohydrate has the research and HCl has the marketing. Creatine HCl is a legitimate way to get creatine into your body if you’re willing to pay more for a powder that mixes cleanly and take enough of it to reach a real dose. What it is not is a more effective form, a lower dose form, or a form that has been shown to do anything for the brain.